Literature DB >> 19919042

High-throughput virtual screening of proteins using GRID molecular interaction fields.

Simone Sciabola1, Robert V Stanton, James E Mills, Maria M Flocco, Massimo Baroni, Gabriele Cruciani, Francesca Perruccio, Jonathan S Mason.   

Abstract

A new computational algorithm for protein binding sites characterization and comparison has been developed, which uses a common reference framework of the projected ligand-space four-point pharmacophore fingerprints, includes cavity shape, and can be used with diverse proteins as no structural alignment is required. Protein binding sites are first described using GRID molecular interaction fields (GRID-MIFs), and the FLAP (fingerprints for ligands and proteins) method is then used to encode and compare this information. The discriminating power of the algorithm and its applicability for large-scale protein analysis was validated by analyzing various scenarios: clustering of kinase protein families in a relevant manner, predicting ligand activity across related targets, and protein-protein virtual screening. In all cases the results showed the effectiveness of the GRID-FLAP method and its potential use in applications such as identifying selectivity targets and tools/hits for new targets via the identification of other proteins with pharmacophorically similar binding sites.

Mesh:

Substances:

Year:  2010        PMID: 19919042     DOI: 10.1021/ci9003317

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

1.  Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A(1), A (2A), A (2B), and A (3) receptor antagonists.

Authors:  Francesco Sirci; Laura Goracci; David Rodríguez; Jacqueline van Muijlwijk-Koezen; Hugo Gutiérrez-de-Terán; Raimund Mannhold
Journal:  J Comput Aided Mol Des       Date:  2012-10-12       Impact factor: 3.686

2.  Crystal structure of the GLP-1 receptor bound to a peptide agonist.

Authors:  Ali Jazayeri; Mathieu Rappas; Alastair J H Brown; James Kean; James C Errey; Nathan J Robertson; Cédric Fiez-Vandal; Stephen P Andrews; Miles Congreve; Andrea Bortolato; Jonathan S Mason; Asma H Baig; Iryna Teobald; Andrew S Doré; Malcolm Weir; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

3.  Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.

Authors:  Miles Congreve; Stephen P Andrews; Andrew S Doré; Kaspar Hollenstein; Edward Hurrell; Christopher J Langmead; Jonathan S Mason; Irene W Ng; Benjamin Tehan; Andrei Zhukov; Malcolm Weir; Fiona H Marshall
Journal:  J Med Chem       Date:  2012-01-27       Impact factor: 7.446

Review 4.  Progress in structure based drug design for G protein-coupled receptors.

Authors:  Miles Congreve; Christopher J Langmead; Jonathan S Mason; Fiona H Marshall
Journal:  J Med Chem       Date:  2011-06-15       Impact factor: 7.446

5.  PoSSuM: a database of similar protein-ligand binding and putative pockets.

Authors:  Jun-Ichi Ito; Yasuo Tabei; Kana Shimizu; Koji Tsuda; Kentaro Tomii
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

6.  BioGPS descriptors for rational engineering of enzyme promiscuity and structure based bioinformatic analysis.

Authors:  Valerio Ferrario; Lydia Siragusa; Cynthia Ebert; Massimo Baroni; Marco Foscato; Gabriele Cruciani; Lucia Gardossi
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

7.  Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.

Authors:  Mathieu Rappas; Ammar A E Ali; Kirstie A Bennett; Jason D Brown; Sarah J Bucknell; Miles Congreve; Robert M Cooke; Gabriella Cseke; Chris de Graaf; Andrew S Doré; James C Errey; Ali Jazayeri; Fiona H Marshall; Jonathan S Mason; Richard Mould; Jayesh C Patel; Benjamin G Tehan; Malcolm Weir; John A Christopher
Journal:  J Med Chem       Date:  2020-01-19       Impact factor: 7.446

8.  2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Penpun Wetwitayaklung; Peter Chiba; Manuel Pastor; Gerhard F Ecker
Journal:  J Comput Aided Mol Des       Date:  2013-02-12       Impact factor: 3.686

9.  Biophysical fragment screening of the β1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.

Authors:  John A Christopher; Jason Brown; Andrew S Doré; James C Errey; Markus Koglin; Fiona H Marshall; David G Myszka; Rebecca L Rich; Christopher G Tate; Benjamin Tehan; Tony Warne; Miles Congreve
Journal:  J Med Chem       Date:  2013-04-09       Impact factor: 7.446

10.  The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu5 receptor case study.

Authors:  Zoltán Orgován; György G Ferenczy; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2019-09-21       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.